A Clinical Study of Apatinib in Patients With Local Progressive/Metastalic Refractory Thyroid Cancer

Condition:   Refractory Cancer
Intervention:   Drug: Apatinib
Sponsor:   Chinese Academy of Medical Sciences
Recruiting - verified June 2017

http://ift.tt/2tiKsPb